Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
imtheramedical.com

See what CB Insights has to offer

Founded Year

2004

Stage

Acquired | Acquired

Total Raised

$19.07M

Valuation

$0000 

About Imthera Medical

ImThera Medical is an early stage company developing a novel, patent pending neurostimulation medical device for the treatment of Obstructive Sleep Apnea (OSA). ImThera's Targeted Hypoglossal Neurostimulation (THN) Sleep Therapy delivers neurostimulation to the tongue during sleep. Using a multi-contact electrode and a programmable pulse generator, the system delivers muscle tone to key tongue muscles, effectively controlling upper airway flow and reducing or eliminating sleep apnea.

Imthera Medical Headquarter Location

12555 High Bluff Drive Suite 310

San Diego, California, 92130,

United States

858-259-2980

Latest Imthera Medical News

Sleep Apnea Devices Market Revenue To Cross USD 11.6 Bn By 2027: Global Market Insights Inc.

Jun 1, 2021

Sleep Apnea Devices Market Revenue To Cross USD 11.6 Bn By 2027: Global Market Insights Inc. The home-care settings & individuals segment in the sleep apnea devices market is predicted to expand at a CAGR of more than 9.5% through 2027, led by rising usage of oral appliances in the home-care settings, treatment availability and emergence of telemedicine & remote care in sleep apnea. Author: Jun 1, 2021 5:30 AM EDT SELBYVILLE, Del., June 1, 2021 /PRNewswire/ -- According to the latest report,  "Sleep Apnea Devices Market by Product (Therapeutics, Diagnostics), End-use (Home Care Settings & Individuals, Sleep Laboratories & Hospitals), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027", by Global Market Insights Inc., the market valuation of sleep apnea devices  will cross $11.6 billion by 2027. High adoption of technologically advanced sleep apnea devices along with the increasing number of sleep apnea disorders across the globe will stimulate the market growth. The increasing geriatric population, availability of insurance coverage for treatment of sleep apnea & other sleep disorders in the U.S., and innovations in sleep apnea devices will spur the industry growth. For instance, the U.S. Health Maintenance Organization, Preferred Provider Organization, and Medicare provide insurance coverage for sleep studies, sleep apnea, and continuous positive airway pressure therapy. According to the IDF Diabetes Atlas, an anticipated 87.6 million people aged 20-79 years were diagnosed with diabetes in the South East Asia region in 2019. Hence, a rising prevalence of chronic conditions associated with sleep ailments is expected to surge the acceptance of sleep apnea devices . Developments in sleep disorder treatment and easily accessible non-invasive options enable faster stabilization in patients. Furthermore, the introduction of smart sleep apnea machines integrated with smart technologies provides an auto-titration to breathe with patients and deliver needed pressure with each inhale, thereby providing better outcomes, assessment, and patient care. Request a sample of this research report @  https://www.gminsights.com/request-sample/detail/489 . The therapeutics segment in the sleep apnea devices market exceeded USD 3.72 billion in 2020 and is poised to witness a 9.9% growth rate by 2027. The benefits of sleep apnea therapeutic devices comprise increasing the air pressure in a patient's throat so that the airway doesn't collapse, helping move mucus from smaller to larger airways, dislodging mucus from the bronchial walls, etc. The high growth rate of the segment is attributable to the rising prevalence of obstructive sleep apnea and correlated co-morbidities. Additionally, the introduction of technologically advanced devices, such as smart airway clearance systems that provide effective bronchiectasis, innovative oral appliance therapy, improved oxygen concentrators, etc., are propelling the segment growth. The surging number of product innovation strategies adopted by key market players will act as a high-impact rendering factor for enhancing the demand for sleep apnea therapeutic devices. Sleep apnea devices market for home-care settings & individuals segment is estimated to attain a CAGR of 9.5% during 2021 to 2027, owing to increasing usage of oral appliances in the home-care settings, treatment availability and emergence of telemedicine & remote care in sleep apnea. Advent of novel devices that integrate signal acquisition and analysis technology would further influence obstructive sleep apnea diagnostics in home-care settings. The use of smartphone-based applications to monitor sleep apnea treatment has improved comfort and convenience in home sleep apnea treatment. Brazil dominated the Latin America sleep apnea devices market and accounted for over USD 198 million in 2020, led by the rising prevalence of sleep disorders, high number of chronic obstructive pulmonary disease (COPD) patients and growing awareness regarding sleep apnea treatment. In Brazil, COPD is one of the leading causes of death, with around 19% prevalence. It is one of the major factors that catalyze the risk of obstructive sleep apnea. In addition, according to a Journal of Clinical Sleep Medicine study, in Brazil, the majority of the participants reported sleep-related complaints such as insomnia, snoring breathing pauses, etc. Moreover, a growing number of leaders entering the market, a large population base of undiagnosed patients and the increasing adoption of oral appliances would augment the sleep apnea devices market demand in the country. Request customization of this research report @  https://www.gminsights.com/roc/489 . Some of the major companies operating in the sleep apnea devices market are BMC Medical, CareFusion Corporation, Cadwell Laboratories, Braebon Medical, Compumedics, Curative Medical, Fisher & Paykel Healthcare, GE Healthcare, ImThera Medical, Invacare Corporation, Natus Medical, Itamar Medical, Philips Healthcare, ResMed, Nihon Kohden, Somnetics International, SOMNOmedics, Weinmann Medical Devices and Teleflex. These participants are implementing several strategic initiatives such as research and development activities to introduce novel sleep apnea devices in the market. Table of Contents (ToC) of the report: Chapter 3   Sleep Apnea Devices Market Insights 3.1    Industry segmentation 3.3    Industry impact forces 3.11    PESTEL analysis About Global Market Insights Inc. Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients penetrative insights and actionable market data specially designed and presented to aid strategic decision-making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology. Contact Us: Related Images sleep-apnea-devices-market-growth.png Sleep Apnea Devices Market Growth Predicted at 9% Through 2027: GMI Major sleep apnea devices market players include BMC Medical, CareFusion Corporation, Cadwell Laboratories, Braebon Medical, Compumedics, Curative Medical, Fisher & Paykel Healthcare, GE Healthcare, ImThera Medical, Invacare Corporation, Natus Medica View original content to download multimedia: http://www.prnewswire.com/news-releases/sleep-apnea-devices-market-revenue-to-cross-usd-11-6-bn-by-2027-global-market-insights-inc-301302208.html SOURCE Global Market Insights Inc. By

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Imthera Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Imthera Medical is included in 3 Expert Collections, including Sleep Health & Wellness.

S

Sleep Health & Wellness

796 items

These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.

M

Medical Devices

7,884 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Digital Health

11,671 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Imthera Medical Patents

Imthera Medical has filed 25 patents.

The 3 most popular patent topics include:

  • Sleep disorders
  • Abnormal respiration
  • Human head and neck
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/24/2018

12/8/2020

Implants (medicine), Neurotechnology, Sleep disorders, Neuroprosthetics, Neurophysiology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/24/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

12/8/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Implants (medicine), Neurotechnology, Sleep disorders, Neuroprosthetics, Neurophysiology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.